1. UBE2L6 is Involved in Cisplatin Resistance by Regulating the Transcription of ABCB6
- Author
-
Kiyoshi Yoshino, Yasuo Morimoto, Chiho Koi, Hiroto Izumi, Tomoko Kurita, and Midori Murakami
- Subjects
Cancer Research ,Cell Survival ,Antineoplastic Agents ,ATP-binding cassette transporter ,03 medical and health sciences ,0302 clinical medicine ,Downregulation and upregulation ,Transcription (biology) ,Gene expression ,Tumor Cells, Cultured ,medicine ,Humans ,RNA, Messenger ,Gene ,Cell Proliferation ,030304 developmental biology ,Pharmacology ,Cisplatin ,0303 health sciences ,Messenger RNA ,Dose-Response Relationship, Drug ,biology ,Chemistry ,ABCB6 ,Drug Resistance, Neoplasm ,030220 oncology & carcinogenesis ,Ubiquitin-Conjugating Enzymes ,biology.protein ,Cancer research ,Molecular Medicine ,ATP-Binding Cassette Transporters ,Drug Screening Assays, Antitumor ,medicine.drug - Abstract
Background: Cisplatin is an important anticancer agent in cancer chemotherapy, but when resistant cells appear, treatment becomes difficult, and the prognosis is poor. Objective: In this study, we investigated the gene expression profile in cisplatin sensitive and resistant cells, and identified the genes involved in cisplatin resistance. Methods: Comparison of gene expression profiles revealed that UBE2L6 mRNA is highly expressed in resistant cells. To elucidate whether UBE2L6 is involved in the acquisition of cisplatin resistance, UBE2L6- overexpressing cells established from cisplatin-sensitive cells and UBE2L6-silenced cells developed from cisplatin- resistant cells were generated, and the sensitivity of cisplatin was examined. Results: The sensitivity of the UBE2L6-overexpressing cells did not change compared with the control cells, but the UBE2L6-silenced cells were sensitized to cisplatin. To elucidate the mechanism of UBE2L6 in cisplatin resistance, we compared the gene expression profiles of UBE2L6-silenced cells and control cells and found that the level of ABCB6 mRNA involved in cisplatin resistance was decreased. Moreover, ABCB6 promoter activity was partially suppressed in UBE2L6-silenced cells. Conclusion: These results suggest that cisplatin-resistant cells have upregulated UBE2L6 expression and contribute to cisplatin resistance by regulating ABCB6 expression at the transcriptional level. UBE2L6 might be a molecular target that overcomes cisplatin resistance.
- Published
- 2020